Rigacci, Luigi
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.395
EU - Europa 682
AS - Asia 190
AF - Africa 1
Totale 2.268
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.395
PL - Polonia 194
IE - Irlanda 135
IT - Italia 135
SE - Svezia 94
HK - Hong Kong 79
CH - Svizzera 41
CN - Cina 41
JO - Giordania 26
FI - Finlandia 20
DE - Germania 19
SG - Singapore 18
RU - Federazione Russa 15
GB - Regno Unito 12
VN - Vietnam 8
TR - Turchia 7
IN - India 5
UA - Ucraina 4
KR - Corea 3
RO - Romania 3
AT - Austria 2
BE - Belgio 2
DK - Danimarca 2
PT - Portogallo 2
FR - Francia 1
IR - Iran 1
MU - Mauritius 1
NL - Olanda 1
PH - Filippine 1
TH - Thailandia 1
Totale 2.268
Salva come PNG Salva come JPEG
Città #
Fairfield 204
Warsaw 192
Ashburn 143
Chandler 141
Dublin 135
Seattle 123
Woodbridge 101
Cambridge 91
Houston 85
Wilmington 72
Hong Kong 50
Ann Arbor 49
Bern 41
Lawrence 38
Altamura 37
Princeton 33
Florence 31
Buffalo 25
Beijing 23
Kent 21
Boston 20
San Diego 17
Boardman 13
Medford 13
Moscow 13
Shanghai 11
Bremen 10
Lappeenranta 9
Norwalk 9
Dong Ket 6
Milan 5
Salerno 5
Sesto Fiorentino 5
Dearborn 4
Falls Church 4
Jacksonville 4
Los Angeles 4
New York 4
Pune 4
Andover 3
Cerea 3
Guangzhou 3
Izmir 3
Latina 3
London 3
Olgiate Olona 3
Redwood City 3
Timisoara 3
Brussels 2
Chengdu 2
Copenhagen 2
Fontebuona 2
Hounslow 2
Pralboino 2
Radomsko 2
Rome 2
Saint Petersburg 2
Seoul 2
Sinalunga 2
Singapore 2
Vienna 2
Washington 2
Angeles City 1
Aprilia 1
Bangkok 1
Central District 1
Council Bluffs 1
Fasano 1
Genova 1
Hillsboro 1
Incisa 1
Kilburn 1
Laurel 1
Lisbon 1
Lucca 1
Nagold 1
Oggiono 1
Old Bridge 1
Paceco 1
Palermo 1
Philadelphia 1
Phoenix 1
Ravenna 1
Redmond 1
Tappahannock 1
Valdobbiadene 1
Wuhan 1
Totale 1.875
Salva come PNG Salva come JPEG
Nome #
Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience 205
MYC protein expression scoring and its impact on the prognosis of aggressive B-cell lymphoma patients 131
Clinical characteristics of interim-PET negative patients with a positive end PET from the prospective HD08-01 FIL study 129
The ion channels and transporters gene expression profile indicates a shift in excitability and metabolisms during malignant progression of Follicular Lymphoma 124
Role of core needle biopsy in primary breast lymphoma 88
Diffusion-Weighted and Perfusion-Weighted MRI to Evaluate Therapeutic Response in Lymphoma: A Comparison with FDG-PET/CT 83
Identification Of Pharmacogenomic Markers Of Clinical Efficacy In A Dose-Dense Therapy Regimen (R-Chop14) In Diffuse Large B Cell Lymphoma 83
Evidence for reduced angiogenesis in bone marrow in SSc: immunohistochemistry and multiparametric computerized imaging analysis. 82
Focal spleen lesions in visceral leishmaniasis, a neglected manifestation of a neglected disease: report of three cases and systematic review of literature 82
Romiplostim before splenectomy in a patient with aggressive non-Hodgkin lymphoma and poor response to platelet transfusions 81
Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessment 81
A gene expression-based model to predict metabolic response after two courses of ABVD in Hodgkin Lymphoma patients 81
Role of Genetic Polymorphisms on Response to R-CHOP regimen in Diffuse Large B-cell Lymphoma Patients: an Interim Analysis of a Multicenter Prospective Pharmacogenetic Study 77
Baseline metabolic tumor volume calculation using different SUV thresholding methods in Hodgkin lymphoma patients: Interobserver agreement and reproducibility across software platforms 72
CLINICAL CHARACTERISTICS OF PATIENTS WITH NEGATIVE INTERIM-PET AND POSITIVE FINAL PET: DATA FROM THE PROSPECTIVE PET-ORIENTED HD0801 STUDY BY FONDAZIONE ITALIANA LINFOMI (FIL) 71
The prognostic value of positron emission tomography performed after two courses (INTERIM-PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL) 71
Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma 69
Feasibility and safety of a reduced duration of therapy of colony-stimulating factor in a dose-dense regimen 68
Nonpeghylated liposomal doxorubicin combination regimen (R-COMP) for the treatment of lymphoma patients with advanced age or cardiac comorbidity 65
Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study. 64
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 64
Single dose palonosetron and dexamethasone in preventing nausea and vomiting induced by high emetogenic ABVD regimen in Hodgkin Lymphoma patients. 61
Pharmacogenomic Markers of Clinical Efficacy in a Dose-Dense Therapy Regimen (R-CHOP14) in Diffuse Large B Cell Lymphoma 57
THE IMPACT OF GENETIC POLYMORPHISMS ON R-CHOP EFFICACY IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: AN INTERIM ANALYSIS OF A MULTICENTER PROSPECTIVE PHARMACOGENETIC STUDY 54
Treatment and prognosis of primary pulmonary lymphoma: a long-term follow-up study 52
Aggressive Disease Course of Multiple Myeloma with Concomitant ALK-Negative Anaplastic Large Cell Lymphoma: A Case Report with an Unusual Presentation 50
CMV AND EBV REACTIVATION AFTER AUTOLOGOUS HAEMOPOIETIC STEM CELL TRANSPLANTATION WITH BEAM CONDITIONING REGIMEN FOR MULTIPLE SCLEROSIS AND LYMPHOMA: A RETROSPECTIVE SINGLE CENTER CASE-CONTROL STUDY 43
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles 38
Pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B cell lymphoma: preliminary results 35
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles 21
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 20
Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV 9
Totale 2.311
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.859
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.859
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019108 0 0 0 0 0 0 0 0 0 0 56 52
2019/2020486 27 21 8 26 60 63 60 66 64 34 39 18
2020/2021378 23 47 7 29 18 32 26 42 33 71 28 22
2021/2022242 1 12 29 17 9 10 14 20 21 11 38 60
2022/2023662 47 120 36 45 37 105 80 43 84 7 11 47
2023/2024283 7 29 34 7 35 38 6 72 7 18 30 0
Totale 2.311